Keith Crandell - Net Worth and Insider Trading
Keith Crandell Net Worth
The estimated net worth of Keith Crandell is at least $310 Million dollars as of 2024-05-23. Keith Crandell is the 10% Owner of Sana Biotechnology Inc and owns about 10,301,250 shares of Sana Biotechnology Inc (SANA) stock worth over $82 Million. Keith Crandell is the Director, 10% Owner of Quanterix Corp and owns about 3,949,685 shares of Quanterix Corp (QTRX) stock worth over $65 Million. Keith Crandell is also the Director, 10% Owner of DA32 Life Science Tech Acquisition Corp and owns about 3,850,000 shares of DA32 Life Science Tech Acquisition Corp (DALS) stock worth over $40 Million. Besides these, Keith Crandell also holds 908 Devices Inc (MASS) , Alnylam Pharmaceuticals Inc (ALNY) , Boundless Bio Inc (BOLD) , Twist Bioscience Corp (TWST) , Adesto Technologies Corp (IOTS) . Details can be seen in Keith Crandell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith Crandell has not made any transactions after 2024-04-02 and currently still holds the listed stock(s).
Transaction Summary of Keith Crandell
Keith Crandell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith Crandell owns 38 companies in total, including Codiak BioSciences Inc (CDAKQ) , Quanterix Corp (QTRX) , and Metacrine Inc (MTCR) among others .
Click here to see the complete history of Keith Crandell’s form 4 insider trades.
Insider Ownership Summary of Keith Crandell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CDAKQ | Codiak BioSciences Inc | 2020-10-13 | 10 percent owner |
QTRX | Quanterix Corp | 2020-11-20 | director & 10 percent owner |
MTCR | Metacrine Inc | 2020-09-15 | 10 percent owner |
2020-02-05 | 10 percent owner | ||
2021-08-12 | director | ||
2021-03-30 | 10 percent owner | ||
2019-08-08 | 10 percent owner | ||
2019-03-07 | 10 percent owner | ||
2019-06-27 | 10 percent owner | ||
2019-06-04 | director | ||
2018-03-27 | 10 percent owner | ||
2019-02-22 | 10 percent owner | ||
2019-02-07 | 10 percent owner | ||
2018-05-23 | 10 percent owner | ||
2018-05-02 | 10 percent owner | ||
2018-04-03 | other: Former 10% owner | ||
2016-10-11 | 10 percent owner | ||
2016-07-20 | 10 percent owner | ||
2016-05-23 | 10 percent owner | ||
2016-03-15 | 10 percent owner | ||
2015-01-14 | 10 percent owner | ||
2014-06-23 | 10 percent owner | ||
2015-02-13 | 10 percent owner | ||
2014-03-17 | 10 percent owner | ||
2013-09-30 | 10 percent owner | ||
2013-06-18 | 10 percent owner | ||
2011-07-21 | 10 percent owner | ||
2004-10-29 | 10 percent owner | ||
2004-05-27 | 10 percent owner | ||
2003-11-26 | 10 percent owner | ||
2020-12-22 | director & 10 percent owner | ||
2021-07-15 | 10 percent owner | ||
2024-02-08 | 10 percent owner | ||
2021-06-16 | 10 percent owner | ||
2021-06-16 | 10 percent owner | ||
2021-07-30 | director & 10 percent owner | ||
2022-10-19 | 10 percent owner | ||
2023-09-14 | 10 percent owner |
Keith Crandell Latest Holdings Summary
Keith Crandell currently owns a total of 8 stocks. Among these stocks, Keith Crandell owns 10,301,250 shares of Sana Biotechnology Inc (SANA) as of February 8, 2024, with a value of $82 Million and a weighting of 26.53%. Keith Crandell owns 3,949,685 shares of Quanterix Corp (QTRX) as of December 11, 2017, with a value of $65 Million and a weighting of 21.11%. Keith Crandell also owns 3,850,000 shares of DA32 Life Science Tech Acquisition Corp (DALS) as of July 30, 2021, with a value of $40 Million and a weighting of 12.82%. The other 5 stocks 908 Devices Inc (MASS) , Alnylam Pharmaceuticals Inc (ALNY) , Boundless Bio Inc (BOLD) , Twist Bioscience Corp (TWST) , Adesto Technologies Corp (IOTS) have a combined weighting of 39.54% among all his current holdings.
Latest Holdings of Keith Crandell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SANA | Sana Biotechnology Inc | 2024-02-08 | 10,301,250 | 7.98 | 82,203,975 |
QTRX | Quanterix Corp | 2017-12-11 | 3,949,685 | 16.56 | 65,406,784 |
DALS | DA32 Life Science Tech Acquisition Corp | 2021-07-30 | 3,850,000 | 10.32 | 39,732,000 |
MASS | 908 Devices Inc | 2020-12-22 | 5,725,045 | 6.57 | 37,613,546 |
ALNY | Alnylam Pharmaceuticals Inc | 2004-05-27 | 222,500 | 149.38 | 33,237,050 |
BOLD | Boundless Bio Inc | 2024-04-02 | 2,230,199 | 10.52 | 23,461,693 |
TWST | Twist Bioscience Corp | 2021-08-12 | 560,475 | 41.36 | 23,181,246 |
IOTS | Adesto Technologies Corp | 2015-10-26 | 400,000 | 12.54 | 5,016,000 |
Holding Weightings of Keith Crandell
Keith Crandell Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith Crandell has made a total of 1 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sana Biotechnology Inc is the acquisition of 1,818,181 shares on February 8, 2024, which cost Keith Crandell around $10 Million.
According to the SEC Form 4 filings, Keith Crandell has made a total of 0 transactions in Quanterix Corp (QTRX) over the past 5 years. The most-recent trade in Quanterix Corp is the acquisition of 266,000 shares on December 11, 2017, which cost Keith Crandell around $4 Million.
According to the SEC Form 4 filings, Keith Crandell has made a total of 1 transactions in DA32 Life Science Tech Acquisition Corp (DALS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DA32 Life Science Tech Acquisition Corp is the acquisition of 1,600,000 shares on July 30, 2021, which cost Keith Crandell around $16 Million.
More details on Keith Crandell's insider transactions can be found in the Insider Trading History of Keith Crandell table.Insider Trading History of Keith Crandell
- 1
Keith Crandell Trading Performance
GuruFocus tracks the stock performance after each of Keith Crandell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith Crandell is 21.13%. GuruFocus also compares Keith Crandell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith Crandell within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Keith Crandell's insider trading performs compared to the benchmark.
Performance of Keith Crandell
Keith Crandell Ownership Network
Ownership Network List of Keith Crandell
Ownership Network Relation of Keith Crandell
Keith Crandell Owned Company Details
What does Codiak BioSciences Inc do?
Who are the key executives at Codiak BioSciences Inc?
Keith Crandell is the 10 percent owner of Codiak BioSciences Inc. Other key executives at Codiak BioSciences Inc include See Remarks Yalonda Howze , Chief Scientific Officer Sriram Sathyanarayanan , and See Remarks Nicole Barna .
Codiak BioSciences Inc (CDAKQ) Insider Trades Summary
Over the past 18 months, Keith Crandell made no insider transaction in Codiak BioSciences Inc (CDAKQ). Other recent insider transactions involving Codiak BioSciences Inc (CDAKQ) include a net sale of 61,535 shares made by Douglas E Williams , a net sale of 20,226 shares made by Linda Bain , and a net sale of 17,534 shares made by Sriram Sathyanarayanan .
In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 129,081 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 129,081 shares.
Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Codiak BioSciences Inc Insider Transactions
Keith Crandell Mailing Address
Above is the net worth, insider trading, and ownership report for Keith Crandell. You might contact Keith Crandell via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.